Optimizing the management of intermediate-stage hepatocellular carcinoma: Current trends and prospects
Hepatocellular carcinoma (HCC) is usually accompanied by chronic liver damage, which sometimes influences the selection of HCC treatment. The Barcelona Clinic Liver Cancer (BCLC) staging system, which was first introduced in 1999, is the most commonly used worldwide. Although the intermediate-stage...
Main Authors: | Takuji Torimura, Hideki Iwamoto |
---|---|
Format: | Article |
Language: | English |
Published: |
Korean Association for the Study of the Liver
2021-04-01
|
Series: | Clinical and Molecular Hepatology |
Subjects: | |
Online Access: | http://e-cmh.org/upload/pdf/cmh-2020-0204.pdf |
Similar Items
-
BCLC-B hepatocellular carcinoma treatment or when should the systemic therapy be started
by: V. V. Breder, et al.
Published: (2018-07-01) -
A novel treatment strategy using indocyanine green for transarterial chemoembolization in BCLC stage C hepatocellular carcinoma
by: Jie Mei, et al.
Published: (2020-01-01) -
Efficacy and Prognostic Factors of Trans-Arterial Chemoembolization Combined With Stereotactic Body Radiation Therapy for BCLC Stage B Hepatocellular Carcinoma
by: Changchen Jiang, et al.
Published: (2021-07-01) -
Hepatocellular Carcinoma: A Review
by: Tarana Gupta
Published: (2020-09-01) -
Significance of liver resection for intermediate stage hepatocellular carcinoma according to subclassification
by: Masateru Yamamoto, et al.
Published: (2021-06-01)